Psychological stress increases expression of aortic plaque intercellular adhesion molecule-1 and serum inflammatory cytokines in atherosclerotic rabbit model

Journal of Geriatric Cardiology

Volumn 5, Issue 4, 2008, Pages 235-242

  Li, Muwei ^a   Wang, Xianpei ^a   Yang, Lei ^a   Gao, Chuanyu ^a   Ma, Yexin ^b  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Atherosclerosis; Inflammation; Plaque stability; Psychological stress

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA WALL; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CONTROLLED STUDY; DRINKING; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPID DIET; MALE; MENTAL STRESS; NONHUMAN; PATHOLOGY; PHYSIOLOGY; RABBIT; RADIOIMMUNOASSAY;

EID: 78649291498     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. J Psychosom Res 2002;52(1):1-23.
2. Strike PC, Magid K, Whitehead DL, et al. Pathophysiological processes underlying emotional triggering of acute cardiac events. Proc Natl Acad Sci USA 2006;103(11):4322-7.
3. Gidron Y, Armon T, Gilutz H, et al. Psychological factors correlate meaningfully with percent-monocytes among acute coronary syndrome patients. Brain Behav Immun 2003;17(4):310-5.
4. Strike PC, Steptoe A. Psychosocial factors in the development of coronary artery disease. Prog Cardiovasc Dis 2004;46(4):337-47.
5. Bunker SJ, Colquhoun DM, Esler MD, et al. "Stress" and coronary heart disease: psychosocial risk factors. Med J Aust 17 2003;178(6):272-6.
6. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340(2):115-26.
7. Elabbassi W, Al-Nooryani A Acute coronary syndrome. An acute inflammatory syndrome. Saudi Med J 2006;27(12):1799-803.
8. Nunez MJ, Balboa J, Riveiro P, et al. Effects of psychological stress and alprazolam on development of oral candidiasis in rats. Clin Diagn Lab Immunol 2002;9(4):852-7.
9. Razzoli M, Roncari E, Guidi A et al. Conditioning properties of social subordination in rats: behavioral and biochemical correlates of anxiety. Horm Behav 2006;50(2):245-51.
10. Bradesi S, Schwetz I, Ennes HS, et al. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol 2005;289(1):G42-53.
11. Imanishi T, Kuroi A, Ikejima H, et al. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits. Hypertens Res 2008;31(3):575-84.
12. de Nigris F, Mancini FP, Balestrieri ML, et al. Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits. Nitric Oxide 2008;19(1):57-63.
13. Kumar SA, Sudhahar V, Varalakshmi P. Protective role of eicosapentaenoate-lipoate (EPA-LA) derivative in combating oxidative hepatocellular injury in hypercholesterolemic atherogenesis. Atherosclerosis 2006;189(1):115-22.
14. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352(16):1685-95.
15. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170(2):191-203.
16. Yotsui T, Yasuda O, Kawamoto H, et al. Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cells. FEBS Lett 2007;581(3):427-32.
17. Yang PY, Rui YC, Lu L, et al. Time courses of vascular endothelial growth factor and intercellular adhesion molecule-1 expressions in aortas of atherosclerotic rats. Life Sci 2005;77(20):2529-39.
18. Szmitko PE, Wang CH, Weisel RD, et al. New markers of inflammation and endothelial cell activation: Part I. Circulation 2003;108(16):1917-23.
19. Yip HK, Sun CK Chang LT, et al. Strong suppression of high-sensitivity C-reactive protein level and its mediated pro-atherosclerotic effects with simvastatin: in vivo and in vitro studies. Int J Cardiol 2007;121(3):253-60.
20. Zouridakis E, Avanzas P, Arroyo-Espliguero R, et al. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004;110(13):1747-53.
21. Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996;127(2):263-71.
22. Hoshi T, Kitagawa K, Yamagami H, et al. Relation between interleukin-6 level and subclinical intracranial large-artery atherosclerosis. Atherosclerosis 2008;197(1):326-32.
23. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001;89(9):763-71.
24. Amar J, Fauvel J, Drouet L, et al. Interleukin 6 is associated with subclinical atherosclerosis: a link with soluble intercellular adhesion molecule 1. J Hypertens 2006;24(6): 1083-8.
25. Owen N, Poulton T, Hay FC, et al. Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress. Brain Behav Immun 2003;17(4):286-95.